Donor-specific Anti-HLA Antibodies Present in Pooled Human Serum Do Not Prevent Development of Human Mreg_UKR From Monocytes in Culture
Authors:
- James A. HutchinsonJHJames A. Hutchinson
- Paloma RiquelmePRPaloma Riquelme
- Christian BachCBChristian Bach
- Tuija KekarainenTKTuija Kekarainen
- Fred FändrichFFFred Fändrich
- Edward K. GeisslerEGEdward K. Geissler
- Norbert AhrensNANorbert Ahrens
- 1 May 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 101 (5) , e188-e190
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Now or never? The case for cell-based immunosuppression in kidney transplantationKidney International, 2015
- Clinical management of patients receiving cell‐based immunoregulatory therapyTransfusion, 2014
- In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapiesMolecular Therapy - Methods & Clinical Development, 2014
- Cutting Edge: Immunological Consequences and Trafficking of Human Regulatory Macrophages Administered to Renal Transplant RecipientsThe Journal of Immunology, 2011
- MHC class II signaling in antigen-presenting cellsCurrent Opinion in Immunology, 2004